Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony-stimulating factor in healthy haploidentical stem cell donors.

Elena Kurnikova Pavel Trakhtman Dmitry Balashov Juliya Garloeva Kumukova Irina Rimma Khismatullina Dmitriy Pershin Larisa Shelikhova Galina A Novichkova Alexey A Maschan

Published in: Vox sanguinis (2022)

The obtained differences in collection were not significant, and thus the application of a decreased dose of plerixafor did not affect the results of mobilization.

Keyphrases

stem cells
peripheral blood
stem cell transplantation
bone marrow
low dose
recombinant human